Maldonado, J
How practical design is changing the game for GLP-1 coverage New research out this week from cardiometabolic care provider 9amHealth, based on 1,000 working-age Americans, found that 93% of those whose employers dont cover GLP-1s for weight loss would take the drug if it was covered
The treatment-regimen estimand represents the estimated average treatment effect regardless of adherence to study intervention or initiation of prohibited weight management treatments (or glycemic rescue therapy for glycemic endpoints only)
M., Mahmoud, A.E.E.-R., & Elkhatib, W
However, a Precision Peptide Genetic Test from PlexusDx can provide context about your peptide-pathway predispositions and support a more informed conversation with your provider about expected response patterns and tolerability
Biomed Pharmacother = Biomed Pharmacother (2020) 130:110523